Mounjaro Dosage for Weight Loss: How Many mg Should You Take?

Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, requires a structured dosing schedule to maximize weight loss while minimizing side effects. Unlike one-size-fits-all approaches, PlexusDx tailors your tirzepatide therapy through genetic testing and clinical assessment to identify the dose range that works best for your body's peptide pathways.

Understanding Tirzepatide Starting Doses

Tirzepatide therapy begins with a low introductory dose designed to allow your digestive system and metabolic receptors to adapt. Most patients start at 2.5 mg once weekly via subcutaneous injection, a dose selected because it activates GLP-1 and GIP signaling without overwhelming your system. This conservative approach reduces nausea and gastrointestinal symptoms during the adaptation phase, typically lasting 2–4 weeks.

The starting dose is intentionally below the therapeutic range because your body needs time to build tolerance to appetite suppression and metabolic changes. Research shows that patients who begin at the lowest dose and titrate upward experience better long-term adherence and report fewer side effects compared to those starting at higher doses. PlexusDx uses baseline metabolic screening and genetic markers to confirm that a standard starting dose aligns with your individual tolerance profile.

Tirzepatide Dose Escalation Schedule

After your initial 2–4 week adjustment period, your dose increases in 2.5 mg increments every four weeks until reaching your target maintenance dose. The typical progression moves from 2.5 mg to 5 mg, then 7.5 mg, then 10 mg, then 12.5 mg, with each step occurring at four-week intervals if tolerability remains good. This gradual escalation allows your GLP-1 and GIP receptors to become fully sensitized while your appetite regulation centers adapt to sustained peptide signaling.

Some patients reach their therapeutic sweet spot at 5 mg or 7.5 mg and choose to remain there rather than advancing further, while others benefit from doses up to 15 mg weekly. The goal is not to reach the maximum dose automatically but to identify the lowest effective dose that produces meaningful weight loss without intolerable side effects. Your clinical team monitors your weekly injection tolerance, gastrointestinal response, and weight loss trajectory at each four-week checkpoint to decide whether to increase, maintain, or adjust your current dose.

How Your Genetics Influence Your Optimal Tirzepatide Dose

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Tirzepatide Injection Pricing and Commitment Options

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) across three flexible commitment tiers, with your dose able to increase while your price remains flat. Unlike traditional pharmacy models where higher doses cost more, PlexusDx's flat-rate pricing means you'll never pay extra as your clinician increases your tirzepatide amount from 2.5 mg toward your maintenance level. This transparent approach eliminates surprise costs and makes budget planning straightforward for your entire weight loss journey.

All PlexusDx tirzepatide comes from licensed 503A compounding pharmacies and is available in all 50 states without insurance requirements or membership fees. HSA and FSA accounts are eligible for payment, maximizing your healthcare flexibility. After your first month of treatment, you may add the Precision Peptide Genetic Test for $99 to unlock personalized dosing insights and optimize your therapeutic response.

Managing Side Effects at Different Tirzepatide Dose Levels

Nausea and loss of appetite are expected during dose escalation phases but typically diminish as your body acclimates over 2–3 weeks at each new dose level. Eating smaller, protein-rich meals and staying hydrated reduce gastrointestinal discomfort without requiring dose reduction in most cases. If side effects persist beyond three weeks at your current dose or become severe, your PlexusDx clinician may recommend staying at your current level longer, slowing titration, or adjusting meal timing and composition to restore tolerability.

Constipation and mild fatigue can occur at higher doses and usually respond to increased fiber intake, hydration, and electrolyte supplementation rather than dose reduction. Serious side effects such as severe abdominal pain, persistent vomiting, or signs of pancreatitis require immediate medical attention and dose discontinuation. Your PlexusDx clinical team monitors your weekly response through secure messaging and adjusts your dosing protocol based on reported tolerability and weight loss progress.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the maximum tirzepatide dose for weight loss?

The maximum labeled tirzepatide dose is 15 mg weekly, though most patients achieve substantial weight loss between 7.5 mg and 12.5 mg. PlexusDx clinicians determine your personal maximum based on your tolerability and weight loss response rather than automatically escalating you to 15 mg. Your genetic profile, baseline metabolic rate, and GLP-1/GIP receptor sensitivity all influence whether higher doses provide additional benefit.

How much weight can you lose on tirzepatide, and does higher dose mean more weight loss?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I stay on a lower tirzepatide dose if it works for me?

Absolutely. Many patients achieve their weight loss goals and maintain them at 5 mg or 7.5 mg weekly and choose not to escalate further. PlexusDx supports dose holding at any level that produces meaningful results with acceptable tolerability; there is no requirement to reach the maximum dose. Your clinician works with you to identify your personal optimal dose rather than following a one-size-fits-all escalation protocol.

How long does tirzepatide titration take, and when do I see weight loss results?

The full titration to your target dose typically takes 8–16 weeks, depending on how quickly your body tolerates each dose increase. Some patients notice appetite suppression and reduced food cravings within the first week, while weight loss usually becomes measurable after 4–6 weeks of consistent injections at therapeutic doses. PlexusDx provides weekly check-ins to monitor your progress and adjust your timeline based on your individual response.

How does the Precision Peptide Genetic Test relate to my GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.